322 related articles for article (PubMed ID: 18599612)
21. Blood-derived amyloid-β protein induces Alzheimer's disease pathologies.
Bu XL; Xiang Y; Jin WS; Wang J; Shen LL; Huang ZL; Zhang K; Liu YH; Zeng F; Liu JH; Sun HL; Zhuang ZQ; Chen SH; Yao XQ; Giunta B; Shan YC; Tan J; Chen XW; Dong ZF; Zhou HD; Zhou XF; Song W; Wang YJ
Mol Psychiatry; 2018 Sep; 23(9):1948-1956. PubMed ID: 29086767
[TBL] [Abstract][Full Text] [Related]
22. Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation.
Kulic L; McAfoose J; Welt T; Tackenberg C; Späni C; Wirth F; Finder V; Konietzko U; Giese M; Eckert A; Noriaki K; Shimizu T; Murakami K; Irie K; Rasool S; Glabe C; Hock C; Nitsch RM
Transl Psychiatry; 2012 Nov; 2(11):e183. PubMed ID: 23149447
[TBL] [Abstract][Full Text] [Related]
23. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
[TBL] [Abstract][Full Text] [Related]
24. Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model.
Thanopoulou K; Fragkouli A; Stylianopoulou F; Georgopoulos S
Proc Natl Acad Sci U S A; 2010 Nov; 107(48):20816-21. PubMed ID: 21076037
[TBL] [Abstract][Full Text] [Related]
25. Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein.
Miao J; Xu F; Davis J; Otte-Höller I; Verbeek MM; Van Nostrand WE
Am J Pathol; 2005 Aug; 167(2):505-15. PubMed ID: 16049335
[TBL] [Abstract][Full Text] [Related]
26. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
[TBL] [Abstract][Full Text] [Related]
27. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
[TBL] [Abstract][Full Text] [Related]
28. Deletion of Abca7 increases cerebral amyloid-β accumulation in the J20 mouse model of Alzheimer's disease.
Kim WS; Li H; Ruberu K; Chan S; Elliott DA; Low JK; Cheng D; Karl T; Garner B
J Neurosci; 2013 Mar; 33(10):4387-94. PubMed ID: 23467355
[TBL] [Abstract][Full Text] [Related]
29. Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways.
Greenberg SM; Bacskai BJ; Hernandez-Guillamon M; Pruzin J; Sperling R; van Veluw SJ
Nat Rev Neurol; 2020 Jan; 16(1):30-42. PubMed ID: 31827267
[TBL] [Abstract][Full Text] [Related]
30. Oligomeric Abeta in Alzheimer's disease: relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy.
van Helmond Z; Miners JS; Kehoe PG; Love S
Brain Pathol; 2010 Mar; 20(2):468-80. PubMed ID: 19725829
[TBL] [Abstract][Full Text] [Related]
31. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
[TBL] [Abstract][Full Text] [Related]
32. Induction of complement proteins in a mouse model for cerebral microvascular A beta deposition.
Fan R; DeFilippis K; Van Nostrand WE
J Neuroinflammation; 2007 Sep; 4():22. PubMed ID: 17877807
[TBL] [Abstract][Full Text] [Related]
33. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.
Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T
Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835
[TBL] [Abstract][Full Text] [Related]
34. A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.
Gkanatsiou E; Portelius E; Toomey CE; Blennow K; Zetterberg H; Lashley T; Brinkmalm G
Neurosci Lett; 2019 May; 701():125-131. PubMed ID: 30807796
[TBL] [Abstract][Full Text] [Related]
35. Abeta42 is essential for parenchymal and vascular amyloid deposition in mice.
McGowan E; Pickford F; Kim J; Onstead L; Eriksen J; Yu C; Skipper L; Murphy MP; Beard J; Das P; Jansen K; DeLucia M; Lin WL; Dolios G; Wang R; Eckman CB; Dickson DW; Hutton M; Hardy J; Golde T
Neuron; 2005 Jul; 47(2):191-199. PubMed ID: 16039562
[TBL] [Abstract][Full Text] [Related]
36. TgCRND8 amyloid precursor protein transgenic mice exhibit an altered gamma-secretase processing and an aggressive, additive amyloid pathology subject to immunotherapeutic modulation.
Van Vickle GD; Esh CL; Kalback WM; Patton RL; Luehrs DC; Kokjohn TA; Fifield FG; Fraser PE; Westaway D; McLaurin J; Lopez J; Brune D; Newel AJ; Poston M; Beach TG; Roher AE
Biochemistry; 2007 Sep; 46(36):10317-27. PubMed ID: 17705508
[TBL] [Abstract][Full Text] [Related]
37. T-cell brain infiltration and immature antigen-presenting cells in transgenic models of Alzheimer's disease-like cerebral amyloidosis.
Ferretti MT; Merlini M; Späni C; Gericke C; Schweizer N; Enzmann G; Engelhardt B; Kulic L; Suter T; Nitsch RM
Brain Behav Immun; 2016 May; 54():211-225. PubMed ID: 26872418
[TBL] [Abstract][Full Text] [Related]
38. Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of Aβ.
Miners JS; Clarke P; Love S
Brain Pathol; 2017 May; 27(3):305-313. PubMed ID: 27248362
[TBL] [Abstract][Full Text] [Related]
39. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
[TBL] [Abstract][Full Text] [Related]
40. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]